ResMed Inc.
$RMD
Public valuation for ResMed Inc. (RMD). Fair value, signal, and key metrics — no sign-in required.
Current Price
$210.98
31% Undervalued
Fair Value Estimate
$277
🏛️
Mature Growth
Profitable company with steady growth
Analyst Consensus
Target: $248.60
18% higher than current
Key Metrics
Market Cap
$30.6B
Forward P/E
18.4x
Operating Margin
34.9%
Revenue Growth
10.3%
PEG Ratio
1.22
Get free watchlist alerts
Join the waitlist for valuation updates on $RMD and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.